IPH.PA
Innate Pharma SA
Price:  
1.50 
EUR
Volume:  
174,924.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IPH.PA Relative Valuation

-234.0%
Upside

As of 2025-07-12, the Relative Valuation of Innate Pharma SA (IPH.PA) is (2.01) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 1.50 EUR, the upside of Innate Pharma SA based on Relative Valuation is -234.0%.

The range of the Relative Valuation is (1.93) - (3.31) EUR.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 2.4x - 6.2x 3.0x
Forward P/E multiples 3.6x - 6.8x 4.5x
Fair Price (1.93) - (3.31) (2.01)
Upside -228.6% - -320.1% -234.0%
1.50 EUR
Stock Price
(2.01) EUR
Fair Price

IPH.PA Relative Valuation - Historical P/E Data

Date P/E
2025-07-11 -2.80
2025-07-10 -2.82
2025-07-09 -2.85
2025-07-08 -2.81
2025-07-07 -2.85
2025-07-04 -2.84
2025-07-03 -2.84
2025-07-02 -2.83
2025-07-01 -2.85
2025-06-30 -2.84
2025-06-27 -2.91
2025-06-26 -2.88
2025-06-25 -2.82
2025-06-24 -2.80
2025-06-23 -2.85
2025-06-20 -2.96
2025-06-19 -3.07
2025-06-18 -3.10
2025-06-17 -3.07
2025-06-16 -3.09
2025-06-13 -3.15
2025-06-12 -3.19
2025-06-11 -3.26
2025-06-10 -3.33
2025-06-09 -3.52
2025-06-06 -3.57
2025-06-05 -3.57
2025-06-04 -3.60
2025-06-03 -3.62
2025-06-02 -3.61
2025-05-30 -3.68
2025-05-29 -3.69
2025-05-28 -3.65
2025-05-27 -3.58
2025-05-26 -3.66
2025-05-23 -3.66
2025-05-22 -3.67
2025-05-21 -3.64
2025-05-20 -3.65
2025-05-19 -3.61
2025-05-16 -3.57
2025-05-15 -3.58
2025-05-14 -3.64
2025-05-13 -3.71
2025-05-12 -3.75
2025-05-09 -3.81
2025-05-08 -3.87
2025-05-07 -3.76
2025-05-06 -3.59
2025-05-05 -3.56